ArticleCureus2026

Pembrolizumab Dual Endocrine Toxicity in a Metastatic Non-small Cell Lung Cancer Patient.

Sawsan Al-Lababidi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.